Citalopram Impurity 21 | CAS 274910-25-7 - Request Quote
Citalopram Impurity 21
| SZ CAT No: | SZ-C039048 |
| CAS No | 274910-25-7 |
| Mol.F. | C18H15ClFNO |
| Mol.Wt. | 315.8 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Citalopram Impurity 21 is chemically 1-(3-Chloropropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile. Citalopram Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Citalopram Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Citalopram.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 274910-25-7
Purchase 274910-25-7
Order 274910-25-7
Enquire 274910-25-7
price of 274910-25-7
274910-25-7 Supplier
274910-25-7 Manufacturer
274910-25-7 Exporter
buy high quality Citalopram Impurity 21
Purchase Citalopram Impurity 21
Citalopram Impurity 21 suppliers
Citalopram Impurity 21 manufacturers
Citalopram Impurity 21 price
Order Citalopram Impurity 21
Enquire Citalopram Impurity 21
Citalopram Impurity 21 cost
Citalopram Impurity 21 Supplier
Citalopram Impurity 21 Distributor
Citalopram Impurity 21 for Method Validation
Citalopram Reference Standard
Citalopram Impurity 21 for ANDA Filing
Citalopram Impurity 21 for Forced Degradation Studies
Citalopram Impurity 21 Identification Standards
Citalopram Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.